adjust adj ep beat conss estim
boost higher net invest incom nii pre-tax p-t margin
japan p-t adj earn rose y/i rais
ep guidanc constant currenc basi
reflect result stronger yen/usd increas ep
japan p-t adj earn grew y/i third
sector sale rose y/i sale new cancer product launch
april high due pent-up demand/low sale well
effici market yen net premium declin total revenu
fell y/i first sector product reach paid-up statu nii rose
y/i driven higher short term interest float rate secur
benefit ratio nearli two percentag point full-year
third sector benefit ratio full-year
benefit ratio help strong sale custom
laps polici bought new cancer insur product long-term
trend reduc hospit day lower benefit ratio
solid perform p-t adj earn
y/i sale rose y/i premium incom rose total revenu
increas y/i expens ratio improv full-year
expect increas due oper invest
benefit ratio vs full-year
corpor p-t adj loss improv vs
primarili due nii gener asset move segment late
last year repurchas share
share remain buy-back author
valuationreiter neutral inform afl call tomorrow
et toll free pass quack
valuat metric
price month
 close
suiss seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid report
singl factor make invest decis
provid supplement health life insur japan
repres earn includ gener
medic disabl accid critic care cancer insur
revenu fee
benefit expens
dac voba
total liabil equiti
earn contribut segment
profit valuat
blue-ski valuat includ stronger yen
higher yield bp would increas net invest incom
reduc recent year due persist low
interest rate environ japan unit state
grey-ski valuat assum decreas
yen/usd bp lower interest rate japan unit
state produc grey-ski scenario
 close
compani mention price
